GENSCRIPT BIO (01548) issued 1.129 million shares as a result of stock options being exercised.

19:43 20/08/2026

Kingserr Biological Technology (01548) announced that on August 20, 2026, it will issue 1,129,000 shares based on the stock options exercised under the post-listing stock option plan approved on December 7, 2015; a total of 5,654,500 new shares will be issued or transferred from treasury shares as share rewards or options granted to the directors of the issuer according to the stock plan.

GENSCRIPT BIO (01548) announced that on August 20, 2026, it will issue 1,129,000 shares upon the exercise of stock options under the post-listing stock option plan approved on December 7, 2015; a total of 5,654,500 new shares will be issued or transferred from treasury shares in connection with share awards or options granted to the directors of the issuer under the stock plan.

TONGDA GROUP (00698) announced its interim results, with profit attributable to shareholders at HKD 49.259 million, a year-on-year decrease of 22.33%.

MAOYAN ENT (01896): Tang Lichun resigns as the company's non-executive director

Shenzhen Hans CNC Technology (03200) announced its interim results, with a net profit attributable to shareholders of approximately 957 million yuan, an increase of 263.45% year-on-year.

TONGDA GROUP (00698) announced its interim results, with profit attributable to shareholders at HKD 49.259 million, a year-on-year decrease of 22.33%.

MAOYAN ENT (01896): Tang Lichun resigns as the company's non-executive director

Shenzhen Hans CNC Technology (03200) announced its interim results, with a net profit attributable to shareholders of approximately 957 million yuan, an increase of 263.45% year-on-year.